Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Sarizotan> ?p ?o }
Showing triples 1 to 86 of
86
with 100 triples per page.
- Sarizotan abstract "Sarizotan (EMD-128,130) is a selective 5-HT1A receptor agonist and D2 receptor antagonist, which has antipsychotic effects, and has also shown efficacy in reducing dyskinesias resulting from long-term anti-Parkinsonian treatment with levodopa.In June 2006, the developer Merck KGaA announced that the development of sarizotan was discontinued, after two sarizotan Phase III studies (PADDY I, PADDY II) failed to meet the primary efficacy endpoint and neither the Phase II findings nor the results from preclinical studies could be confirmed. No statistically significant difference of the primary target variable between sarizotan and placebo could be demonstrated.".
- Sarizotan atcPrefix "none".
- Sarizotan casNumber "177975-08-5".
- Sarizotan fdaUniiCode "467LU0UCUW".
- Sarizotan iupacName "1-[(2R)-3,4-dihydro-2H-chromen-2-yl]-N-([5-(4-fluorophenyl)pyridin-3-yl]methyl)methanamine".
- Sarizotan pubchem "6918388".
- Sarizotan thumbnail Sarizotan.png?width=300.
- Sarizotan wikiPageID "26637162".
- Sarizotan wikiPageLength "5863".
- Sarizotan wikiPageOutDegree "18".
- Sarizotan wikiPageRevisionID "681396760".
- Sarizotan wikiPageWikiLink 5-HT1A_receptor.
- Sarizotan wikiPageWikiLink Agonist.
- Sarizotan wikiPageWikiLink Antagonist_(pharmacology).
- Sarizotan wikiPageWikiLink Antipsychotic.
- Sarizotan wikiPageWikiLink Binding_selectivity.
- Sarizotan wikiPageWikiLink Category:Abandoned_drugs.
- Sarizotan wikiPageWikiLink Category:Amines.
- Sarizotan wikiPageWikiLink Category:Chromanes.
- Sarizotan wikiPageWikiLink Category:Organofluorides.
- Sarizotan wikiPageWikiLink Category:Pyridines.
- Sarizotan wikiPageWikiLink Dopamine_receptor_D2.
- Sarizotan wikiPageWikiLink Dyskinesia.
- Sarizotan wikiPageWikiLink L-DOPA.
- Sarizotan wikiPageWikiLink Levodopa.
- Sarizotan wikiPageWikiLink Merck_KGaA.
- Sarizotan wikiPageWikiLink Osemozotan.
- Sarizotan wikiPageWikiLink Parkinsons_disease.
- Sarizotan wikiPageWikiLink Piclozotan.
- Sarizotan wikiPageWikiLink Receptor_antagonist.
- Sarizotan wikiPageWikiLink Robalzotan.
- Sarizotan wikiPageWikiLinkText "Sarizotan".
- Sarizotan wikiPageWikiLinkText "sarizotan".
- Sarizotan atcPrefix "none".
- Sarizotan c "22".
- Sarizotan casNumber "177975".
- Sarizotan chemspiderid "2319847".
- Sarizotan f "1".
- Sarizotan h "21".
- Sarizotan hasPhotoCollection Sarizotan.
- Sarizotan iupacName "1".
- Sarizotan legalStatus "Discontinued".
- Sarizotan molecularWeight "348.413".
- Sarizotan n "2".
- Sarizotan o "1".
- Sarizotan pregnancyCategory "N/A".
- Sarizotan pubchem "6918388".
- Sarizotan routesOfAdministration "Oral".
- Sarizotan smiles "C1CC2=CC=CC=C2O[C@H]1CNCC3=CN=CCC4=CC=CF".
- Sarizotan unii "467".
- Sarizotan wikiPageUsesTemplate Template:Antiparkinsonian.
- Sarizotan wikiPageUsesTemplate Template:Antipsychotics.
- Sarizotan wikiPageUsesTemplate Template:Dopaminergics.
- Sarizotan wikiPageUsesTemplate Template:Drugbox.
- Sarizotan wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- Sarizotan wikiPageUsesTemplate Template:Reflist.
- Sarizotan wikiPageUsesTemplate Template:Serotonergics.
- Sarizotan subject Category:Abandoned_drugs.
- Sarizotan subject Category:Amines.
- Sarizotan subject Category:Chromanes.
- Sarizotan subject Category:Organofluorides.
- Sarizotan subject Category:Pyridines.
- Sarizotan hypernym HT.
- Sarizotan type ChemicalSubstance.
- Sarizotan type Drug.
- Sarizotan type Group.
- Sarizotan type Drug.
- Sarizotan type Group.
- Sarizotan type Heterocycle.
- Sarizotan type Organofluoride.
- Sarizotan type Organohalide.
- Sarizotan type Organofluoride.
- Sarizotan type Organohalide.
- Sarizotan type ChemicalObject.
- Sarizotan type Thing.
- Sarizotan type Q8386.
- Sarizotan comment "Sarizotan (EMD-128,130) is a selective 5-HT1A receptor agonist and D2 receptor antagonist, which has antipsychotic effects, and has also shown efficacy in reducing dyskinesias resulting from long-term anti-Parkinsonian treatment with levodopa.In June 2006, the developer Merck KGaA announced that the development of sarizotan was discontinued, after two sarizotan Phase III studies (PADDY I, PADDY II) failed to meet the primary efficacy endpoint and neither the Phase II findings nor the results from preclinical studies could be confirmed. ".
- Sarizotan label "Sarizotan".
- Sarizotan sameAs m.0bh9q3x.
- Sarizotan sameAs Sarizotan.
- Sarizotan sameAs Sarizotan.
- Sarizotan sameAs Q7424144.
- Sarizotan sameAs Q7424144.
- Sarizotan wasDerivedFrom Sarizotan?oldid=681396760.
- Sarizotan depiction Sarizotan.png.
- Sarizotan isPrimaryTopicOf Sarizotan.